IN GOOD HEALTH: Alzheimer’s Research Shifting from Late-Stage Treatment to Early Detection

A Year of Firsts for Alzheimer's Blood Testing

Alzheimer’s blood testing has advanced in the past year with the first FDA-cleared tests and clinical guidelines, impacting lab workflows.

IN GOOD HEALTH: Alzheimer’s Research Shifting from Late-Stage Treatment to Early Detection

By Leanna Coy, FNP-BC KEY TAKEAWAYS: • FDA-approved blood tests are now available to aid in diagnosing Alzheimer’s disease. • Currently, 11% of people age 65 and older have Alzheimer’s. That number is expected to double by 2050. • A positive blood test result alone does not confirm an Alzheimer’s diagnosis. Marva moved in with her youngest daughter’s family after her husband died. She lived in her own apartment in the home and helped care for he…